What is ATHXQ stock price today?

ATHXQ (Athersys Inc) stock is trading at $0.00 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ATHXQ stock going up or down today?

ATHXQ stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ATHXQ stock now?

The decision to buy ATHXQ depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ATHXQ a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ATHXQ based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ATHXQ stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ATHXQ is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ATHXQ's P/E ratio?

P/E ratio data for ATHXQ will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ATHXQ's market cap?

ATHXQ (Athersys Inc) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is ATHXQ's price to book ratio?

Price-to-book ratio for ATHXQ is available on our dashboard along with other valuation metrics.

Does ATHXQ pay dividends?

ATHXQ does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ATHXQ's dividend yield?

ATHXQ does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ATHXQ stock a good long-term investment?

ATHXQ's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ATHXQ's revenue growth rate?

Revenue growth data for ATHXQ is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ATHXQ are available on our dashboard with complete income statement analysis.

What are the risks of investing in ATHXQ?

Key risks for ATHXQ include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ATHXQ compare to its competitors?

Compare ATHXQ to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ATHXQ's performance and positioning.

What is ATHXQ's stock price target for 2026?

Our AI model provides price targets for ATHXQ based on fundamental analysis: Bull case $0.00 (+30%), Base case $0.00 (+15%), Bear case $0.00 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ATHXQ?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ATHXQ. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ATHXQ's next earnings report?

ATHXQ reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ATHXQ - Athersys Inc

NYSE * Health Care * Biotechnology

$0.00

+$0.00 (+0.00%)

About Athersys Inc

Athersys, Inc., a clinical-stage biotechnology company, develops therapies in the regenerative medicine area. Its stem cell product candidate is the MultiStem cell therapy, an allogeneic stem cell product for the treatment of indications in the neurological, inflammatory and immune, and cardiovascular disease areas, as well as other critical care conditions. The company was founded in 1995 and is headquartered in Cleveland, Ohio. On September 24, 2024, the voluntary petition of Athersys, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy along with its affiliates on January 5, 2024.

ATHXQ Key Statistics

Market Cap

$0.01M

EPS

$-16.50

Employees

How ATHXQ Compares to Peers

ATHXQ is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ATHXQ(This stock)	$6.17K	N/A	0%	0.0%	-
AMGNAmgen Inc	$186.47B	24.3	0%	0.2%	vs AMGN
GILDGilead Sciences	$164.96B	19.6	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$111.33B	28.6	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$78.93B	18.0	0%	0.3%	vs REGN
BIIBBiogen Inc	$27.89B	21.6	-0%	0.1%	vs BIIB

Athersys Inc Company Information

Headquarters: Ohio; U.S.A
Website: www.athersys.com
Sector: Health Care
Industry: Biotechnology

Data Updated: April 24, 2026 at 2:01 PM EDT

Ready to invest in ATHXQ?

Commission-free trading available. Affiliate links.

Upcoming Events for ATHXQ

Dashboard

Enter a ticker to analyze